- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Volume in Canada
Total 295 results
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Belgium, France, Germany, Italy, Japan, Spain
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
AmgenCompleted
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
Janssen-Cilag Ltd.CompletedMultiple MyelomaBrazil, Argentina, Mexico, Colombia, Panama
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
Kiadis PharmaTerminatedLymphoma | Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Myelodysplastic Syndrome | Lymphoblastic LeukemiaCanada, Netherlands, Germany, Belgium, United States, Italy, United Kingdom
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Spain, Japan, Australia
-
Janssen-Cilag Ltd.CompletedLymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | LymphoidArgentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
-
PETHEMA FoundationCompletedRelapsed and Refractory Multiple MyelomaSpain
-
PfizerRecruitingMultiple MyelomaUnited States, Japan, Spain, Canada, Finland, Argentina, Norway
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Genzyme, a Sanofi CompanyCompletedMultiple MyelomaUnited States, Canada, Germany
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
TeneoOne Inc.RecruitingMultiple MyelomaIsrael, United States, Canada, Spain, France, Denmark, United Kingdom
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
TakedaActive, not recruitingMultiple MyelomaSpain, United States, Australia, China, Korea, Republic of, Canada, France
-
National Cancer Institute (NCI)RecruitingNeoplasms | Multiple Myeloma | Myelodysplastic Syndrome | LymphomasUnited States, Canada
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple MyelomaUnited States, Canada
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
-
Fundación Española de Hematología y HemoterapíaRecruitingWaldenstrom MacroglobulinemiaSpain
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Japan, Puerto Rico
-
BayerWithdrawnMultiple MyelomaBelgium, Spain, Korea, Republic of, Taiwan, United States, Australia, Germany, Israel, Italy, Greece, Canada
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
Novartis PharmaceuticalsActive, not recruitingMultiple MyelomaSaudi Arabia, Germany, Singapore, Italy, France, Israel, United Kingdom, Japan, Australia, Spain, Brazil, United States, Greece, Canada
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
CelgeneApproved for marketingMultiple MyelomaUnited States, Canada
-
TakedaCompleted
-
Regeneron PharmaceuticalsRecruiting
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece